[ad_1] Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of the thousands of lawsuits […]
Continue readingTag: Biotechnology
CVS shares plummet as health company slashes profit outlook on higher medical costs
[ad_1] CVS Health on Wednesday reported first-quarter revenue and adjusted earnings that missed expectations and slashed its full-year profit outlook, citing higher medical costs that […]
Continue readingPfizer beats revenue estimates, raises profit outlook on cost cuts and smaller-than-feared drop in Covid drug sales
[ad_1] Jakub Porzycki | Nurphoto | Getty Images Pfizer on Wednesday reported first-quarter revenue that beat expectations and hiked its full-year profit outlook, benefiting from […]
Continue readingFTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
[ad_1] A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. Lee Smith | Reuters The Federal […]
Continue readingEli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
[ad_1] Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020. Mike Blake | Reuters Eli […]
Continue readingWalmart to shutter health centers, virtual care service in latest failed push into health care
[ad_1] Walmart on Tuesday said it will close all of its health-care clinics across the country, a stunning reversal of its plans to bring its […]
Continue readingJudge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
[ad_1] Jonathan Raa | Nurphoto | Getty Images A federal judge in New Jersey on Monday rejected Johnson & Johnson‘s and Bristol Myers Squibb‘s legal […]
Continue readingA CVS Health pharmacy in Vegas becomes first to join new national pharmacy union
[ad_1] A CVS Omnicare pharmacy in Las Vegas has become the first location to join a new national pharmacy union, a milestone for organizers trying […]
Continue readingFDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
[ad_1] The Food and Drug Administration on Friday announced that the agency approved Pfizer‘s treatment for a rare genetic bleeding disorder, making it the company’s […]
Continue readingMerck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
[ad_1] The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5, 2024. Spencer Platt | Getty Images Merck on […]
Continue reading